The Clinical Landscape Of ADCs In 2023 Diverse Technologies Narrow Target
Antibody-drug conjugates (ADCs) are a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the potency of...
Source: pharmaceuticalonline.com